We are live on ! Find out more
RVNC

Revance Therapeutics, Inc.
RVNC

Delisted

RVNC was delisted on the 5th of February, 2025.

Back to rankings

66 hedge funds and large institutions have $373M invested in Revance Therapeutics, Inc. in 2014 Q1 according to their latest regulatory filings, with 66 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
66
Holders Change
+66
Holders Change %
–
% of All Funds
1.91%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
66
Increased
–
Reduced
–
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
EWM
Essex Woodlands Management
Texas
+$143M
2
VAM
Visium Asset Management
New York
+$28.1M
3
WRF
Waddell & Reed Financial
Kansas
+$16.6M
4
CWAM
Columbia Wanger Asset Management
Illinois
+$16.2M
5
Millennium Management
Millennium Management
New York
+$10M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Citadel Advisors
26
Citadel Advisors
Florida
$2.54M +$2.52M +80,600 New
State Street
27
State Street
Massachusetts
$2.06M +$2.05M +65,495 New
Morgan Stanley
28
Morgan Stanley
New York
$1.98M +$1.96M +62,820 New
Principal Financial Group
29
Principal Financial Group
Iowa
$1.89M +$1.87M +60,000 New
BA
30
BlackRock Advisors
Delaware
$1.56M +$1.55M +49,666 New
Federated Hermes
31
Federated Hermes
Pennsylvania
$1.56M +$1.55M +49,490 New
RPAM
32
Rhenman & Partners Asset Management
Sweden
$1.55M +$1.54M +49,135 New
UBS AM
33
UBS AM
Illinois
$1.52M +$1.51M +48,300 New
LCS
34
Levin Capital Strategies
New York
$1.48M +$1.47M +46,954 New
TG
35
TCW Group
California
$1.39M +$1.38M +44,082 New
PAM
36
Panagora Asset Management
Massachusetts
$1.22M +$1.21M +38,573 New
Geode Capital Management
37
Geode Capital Management
Massachusetts
$1.11M +$1.1M +35,143 New
Northern Trust
38
Northern Trust
Illinois
$901K +$893K +28,591 New
SONJCPFA
39
State of New Jersey Common Pension Fund A
New Jersey
$819K +$812K +26,000 New
SI
40
Standard Investments
New York
$797K +$790K +25,300 New
EEG
41
E.E. Geduld
$788K +$781K +25,000 New
TCIM
42
TIAA CREF Investment Management
New York
$695K +$690K +22,078 New
GPCM
43
Granite Point Capital Management
Massachusetts
$680K +$675K +21,600 New
GTC
44
Ghost Tree Capital
New York
$630K +$625K +20,000 New
ACH
45
ArrowMark Colorado Holdings
Colorado
$615K +$610K +19,527 New
BIM
46
BlackRock Investment Management
Delaware
$605K +$600K +19,200 New
Bank of New York Mellon
47
Bank of New York Mellon
New York
$576K +$572K +18,294 New
BAMCO Inc
48
BAMCO Inc
New York
$551K +$547K +17,500 New
NFA
49
Nationwide Fund Advisors
Ohio
$476K +$472K +15,118 New
PIM
50
Partner Investment Management
California
$397K +$393K +12,590 New
1
2
3

RVNC Hedge Fund Activity: Q1 2014 in Review

66 of the 3,464 institutional investors tracked by Wall St. Rank reported a position in Revance Therapeutics, Inc. (RVNC) for Q1 2014, worth a combined $373M.

Buyers outnumbered sellers: 66 funds opened new RVNC positions and 0 closed out — a net gain of 66 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Essex Woodlands Management, opening a new position worth an estimated $143M.

  • 66 institutional investors held Revance Therapeutics, Inc. (RVNC) as of Q1 2014, up from 0 in Q4 2013.
  • Funds reported $373M of Revance Therapeutics, Inc. stock for Q1 2014.
  • 66 funds opened new Revance Therapeutics, Inc. positions in Q1 2014 and 0 closed out, a net change of +66 holders.
  • The largest Revance Therapeutics, Inc. buyer in Q1 2014 was Essex Woodlands Management, an estimated $143M added.

Based on aggregated 13F filings for Q1 2014.